Celanese Corp Form 8-K Summary
Business Context and Reporting Period
This Current Report (Form 8-K) was filed by Celanese Corporation on January 19, 2009. The report addresses material impairments recognized during the fourth quarter of 2009 related to potential facility closures in France and Mexico.
Key Financial Metrics
- Impairment Charge: A non-cash charge in the range of $90 million to $100 million related to fixed production assets.
- Cash Impact: Approximately $6 million of the impairment charge is anticipated to be future cash expenditures.
- Other Metrics: The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The Company concluded that certain fixed production assets were impaired due to the potential closure of:
- The acetic acid and vinyl acetate monomer (VAM) production facility in Pardies, France.
- The VAM production unit in Cangrejera, Mexico.
- Certain other actions the Company is considering.
Outlook, Risks, and Management Commentary
On January 21, 2009, the Company issued a press release (Exhibit 99.1) announcing the assessment of the potential closures mentioned above. The impairment reflects the financial impact of these strategic decisions. The filing does not provide specific forward-looking guidance, risk factors, or contingencies beyond the immediate asset impairment and associated cash outflows.
Investor Verification Checklist
- Verify the final decision regarding the closure of the Pardies, France, and Cangrejera, Mexico facilities.
- Confirm the exact final impairment amount within the $90 million to $100 million range in the next quarterly report.
- Monitor the timing and total cost of the anticipated $6 million in future cash expenditures.
- Review the attached press release (Exhibit 99.1) for additional operational details.